These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 913715)

  • 1. [Increases of serum gastrin and growth hormone concentrations in subjects suffering from hyperthyroidism, hypothyroidism, and in patients with partial gastrectomy, and normal subjects in the per-oral administration of glycine].
    Kobayashi M
    Nihon Naibunpi Gakkai Zasshi; 1977 Jul; 53(7):854-71. PubMed ID: 913715
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum gastrin levels in patients with thyroid dysfunction.
    Sagara K; Shimada T; Fujiyama S; Sato T
    Gastroenterol Jpn; 1983 Apr; 18(2):79-83. PubMed ID: 6852440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth hormone during administration of adrenocortical steroids in thyroid diseases].
    Takei T
    Nihon Shonika Gakkai Zasshi; 1971 Dec; 75(12):1114-25. PubMed ID: 5168437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fasting serum gastrin, motilin and secretin in treated and untreated hyperthyroidism].
    Aoyagi K; Murakami S; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1983 Jun; 59(6):835-46. PubMed ID: 6617923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum gastrin level before and after gastrectomy following oral administration of glycine].
    Fukuchi K
    Nihon Geka Hokan; 1984 Jan; 53(1):145-56. PubMed ID: 6497542
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of hypergastrinemia in patients with hyper- and hypothyroidism: impact for calcitonin?
    Vierhapper H; Nowotny P; Bieglmayer Ch; Gessl A
    Horm Res; 2002; 57(3-4):85-9. PubMed ID: 12006703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of tolbutamide-induced hypoglycemia on serum gastrin concentration in normal control, hyperthyroidism, primary hypothyroidism and diabetes mellitus (author's transl)].
    Kobayashi M; Shimoda SI; Kasai K
    Nihon Naibunpi Gakkai Zasshi; 1978 Feb; 54(2):143-57. PubMed ID: 640095
    [No Abstract]   [Full Text] [Related]  

  • 8. [Growth hormone in patients with hyperthyroidism and hypothyroidism].
    Odavić M; Antić M; Palmar J; Lazarov J
    Srp Arh Celok Lek; 1977; 105(3-4):261-9. PubMed ID: 929328
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum levels of growth hormone in the course of insulin-induced hypoglycemia in hyperthyroidism and hypothyroidism].
    Schneider E
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1311-3. PubMed ID: 1161571
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum gastrin and motilin in treated and untreated hyperthyroidism.
    Aoyagi K; Mishima Y; Murakami S; Ito K
    Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):153-9. PubMed ID: 6959740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum digoxin in patients with thyroid disease.
    Croxson MS; Ibbertson HK
    Br Med J; 1975 Sep; 3(5983):566-8. PubMed ID: 1100180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory effect of glycine on human growth hormone secretion.
    Kasai K; Kobayashi M; Shimoda SI
    Metabolism; 1978 Feb; 27(2):201-8. PubMed ID: 622050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin behavior in thyroid disorders of childhood.
    Hayek A; Maloof F; Crawford JD
    Pediatr Res; 1973 Jan; 7(1):28-38. PubMed ID: 4119824
    [No Abstract]   [Full Text] [Related]  

  • 15. Increase of serum GH concentration following TRH injection in patients with primary hypothyroidism.
    Hamada N; Uoi K; Nishizawa Y; Okamoto T; Hasegawa K
    Endocrinol Jpn; 1976 Feb; 23(1):5-10. PubMed ID: 819254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of synthetic "thyrotropin-releasing factor" on plasma levels of thyrotropin and growth hormone in healthy subjects and patients with hyperthyroidism or primary hypothyroidism.
    zur Mühlen A von ; Hesch RD; Emrich D; Creutzfeldt W
    Ger Med Mon; 1971; 1(1):1-2. PubMed ID: 4103049
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentrations of somatomedins and growth hormone in relation to bone metabolism in acromegaly and thyroid dysfunction.
    Bijlsma JW; Duursma SA
    Clin Exp Rheumatol; 1986; 4(2):105-10. PubMed ID: 3731567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of endogenous gastrin release to affect serum insulin.
    Budillon G; Mazzacca G; Squame G
    Digestion; 1973; 8(3):201-07. PubMed ID: 4578779
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypogastrinemia in hypothyroidism.
    Seino Y; Matsukura S; Inoue Y; Kadowaki S; Mori K; Imura H
    Am J Dig Dis; 1978 Feb; 23(2):189-91. PubMed ID: 623084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.